A Clinical Trial to Evaluate the Effects of an Omega-3-containing Supplement on DHA and EPA Levels in the Blood
Revive Active
Summary
This is a 12-week, hybrid, single-arm clinical trial designed to evaluate the effects of an omega-3-containing supplement (Omega Active) on DHA and EPA levels in the blood. Forty participants will take two capsules of the test product daily and complete study-specific questionnaires at Baseline, Week 4, Week 8, and Week 12, while also attending their local Quest Diagnostics Center at Baseline and Week 12 for blood biomarker testing. The study will also assess participants' perceptions of the effects of the test product on cognitive performance, gastrointestinal symptoms, and overall health through self-reported questionnaires. There is no randomization or blinding; all participants will receive the active supplement for the full 12-week intervention period.
Eligibility
- Age range
- 18–65 years
- Sex
- All
- Healthy volunteers
- Yes
Inclusion Criteria: * Be male or female. * Be aged 18-65. * Anyone in good general health. * Willing to avoid taking other supplements, prescription medications, or herbal remedies that target DHA or EPA levels in the body, for the duration of the study. * Must not have taken fish oil or plant-based omega oil supplements in the past eight weeks. * Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study. * Resides in the United States. Exclusion Criteria: * Anyone with pre-existing chronic conditions that would prevent participants from adheri…
Interventions
- Dietary SupplementOmega Active Supplement
All participants receive one dose (two capsules) of the Omega Active omega-3 supplement daily for 12 weeks.
Location
- CitruslabsLas Vegas, Nevada